Application of the DHPLC method for mutational detection of the CYP21A2 gene in congenital adrenal hyperplasia

Clinica Chimica Acta

Volumn 410, Issue 1-2, 2009, Pages 48-53

  Tsai, Li Ping ^a   Cheng, Ching Feng ^a,b,c   Hsieh, Jo Ping ^d   Teng, Ming sheng ^a   Lee, Hsien Hsiung ^e  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CAH; Chromatography; CYP21A2; DHPLC; Mutational detection; PCR based amplification

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2;

AMPLICON; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GENE DUPLICATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOGENE; SEQUENCE HOMOLOGY; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; GENETIC TESTING; HUMANS; METHODS; POLYMERASE CHAIN REACTION; PSEUDOGENES; RECOMBINATION, GENETIC; STEROID 21-HYDROXYLASE;

EID: 70350566134     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.020     Document Type: Article

References (41)

1. New M.I., and Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineral corticoid excess. Pro Natl Acad Sci USA 96 (1999) 12790-12797
2. New M.I. Extensive clinical experience nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91 (2006) 4205-4214
3. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21 (2000) 245-291
4. Therrel B.L. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin N Am 30 (2001) 15-30
5. Fitness J., Dixit N., Webster D., et al. Genotyping of CYP21, linked chromosome 6p marker, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 84 (1999) 960-966
6. Koppens P.F.J., Hoogenboezem T., and Degenhart H.J. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB-TNXA hybrids in apparent large-scale gene conversions. Hum Mol Genet 11 (2002) 2581-2590
7. Lee H.H. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Mol Genet Metab 84 (2005) 4-8
8. Lee H.H. CYP21 mutations and congenital adrenal hyperplasia. Clin Genet 59 (2001) 293-301
9. Stikkelbroeck N.M.M.L., Hoefsloot L.H., de Wijs I.J., Otten B.J., Hermus A.R.M.M., and Sistermans E.A. CYP21 Gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88 (2003) 3852-3859
10. Dain L.B., Buzzalino N.D., Oneto A., et al. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Clin Endocrinol 56 (2002) 239-245
11. Lee H.H., Kuo J.M., Chao H.T., et al. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 85 (2000) 597-600
12. Wilson R.C., Nimkarn S., Dumic M., et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 90 (2007) 414-421
13. Lee H.H., Lee Y.J., Chen P., and Lin C.Y. Use of PCR-based amplification analysis as a substitute for the Southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. Clin Chem 50 (2004) 1074-1076
14. Friaes A., Rego A.T., Aragues J.M., et al. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab 88 (2006) 58-65
15. Koyama S., Toyoura T., Saisho S., Shmozawa K., and Yata J. Genetic analysis of Japanese patients with steroid 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 87 (2002) 2668-2673
16. Kharrat M., Tardy V., M'rad R., et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89 (2004) 368-374
17. Robins T., Barbaro M., Lajic S., and Wedell A. Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia. J Clin Endocrinol Metab 90 (2005) 2148-2153
18. Lee H.H., Chao M.C., and Lee Y.J. Only two amino acid substitutions of I236N and V237E in exon 6 are converted to the CYP21 gene in a Chinese patient with congenital adrenal hyperplasia. Clin Endocrinol 64 (2006) 227-229
19. Human Gene Mutation Database (HGMD) Cytochrome P450, subfamily XXIA (steroid 21-hydroxylase, congenital adrenal hyperplasia), peptide 2. http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120605.html
20. Concolino P., Mello E., Minucci A., et al. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med Genet 10 (2009) 72
21. Burch G.H., Gong Y., Liu W., et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17 (1997) 104-108
22. Schalkwijk J., Zweers M.C., Steijlen P.M., et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345 (2001) 1167-1175
23. Lee H.H., Lee Y.J., Wang Y.M., et al. Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency. Mol Genet Metab 93 (2008) 450-457
24. Loidi L., Quinteiro C., Parajes S., et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect. Clin Endocrinol 64 (2006) 330-336
25. Owerbach D., Crawford Y.M., and Draznin M.B. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. Mol Endocrinol 4 (1990) 125-131
26. Day D.J., Speiser P.W., White P.C., and Barany F. Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics 29 (1995) 152-162
27. Keen-Kim D., Redman J.B., Alanes R.U., et al. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagnostics 7 (2005) 236-246
28. Wilson R.C., Wei J.Q., Chen K.C., Mercado A.B., and New M.I. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 80 (1995) 1635-1640
29. Tajima T., Fujieda K., Nakayama K., and Fujii-Kuriyama Y. Molecular analysis of patients and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformational polymorphism. J Clin Invest 92 (1993) 2182-2190
30. Lee H.H., Chao H.T., Ng H.T., and Choo K.B. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 33 (1996) 371-375
31. Krone N., Braun A., Weinert S., et al. Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 48 (2002) 818-825
32. Zeng X., Witchel S.F., Dobrowolski S.F., Moulder P.V., Jarvik J.W., and Telmer C.A. Detection and assignment of CYP21 mutations using peptide mass signature genotyping. Mol Genet Metab 82 (2004) 38-47
33. Higashi Y., Yoshioka H., Yamane M., Gotoh O., and Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and genuine gene. Proc Natl Acad Sci USA 83 (1986) 2841-2845
34. Higashi Y., Hiromasa T., Tanae A., et al. Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem (Tokyo) 109 (1991) 638-644
35. Fardella C.E., Hum D.W., Rodriguez H., et al. Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency. J Clin Endocrinol Metab 81 (1996) 321-326
36. New M.I. An update of congenital adrenal hyperplasia. Ann NY Acad Sci 1038 (2004) 14-43
37. Jones A.C., Sampson J.R., and Cheadle J.P. Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum Mutat 17 (2001) 233-234
38. Xiao W., and Oefiner P.J. Denaturing high-performance liquid chromatography: a review. Hum Mutat 17 (2001) 439-474
39. Stanford Genome Technology Center, DNA Variation Group. DHPLC, Human gene screen by DHPLC. http://insertion.stanford.edu/dhplc_genes_DHPLC.pdf.
40. L'Allemand D., Tardy V., Gruters A., Schnabel D., Krude H., and Morel Y. How a patient homozygous for a 30-kb deletion of the C4-CYP21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 85 (2000) 4562-4567
41. Tusie-Luna M.T., Speiser P.W., Dumic M., New M.I., and White P.C. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5 (1991) 685-692